Type 2 Diabetes Flashcards

1
Q

what is the pathophysiology of T2DM

A

genetic disposition + obesity lifestyle factors

insulin resistance
=
compensatoy beta cell hyperplasia (normoglycemia)
=
early beta cell failure (impaired glucose tolerance- pre diabetes)
=
beta cell failure late (diabetes)

can also be caused by primary beta cell failure (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the components of the ominous octet that contribute to hyperglycaemia in T2DM

A
decreased insulin secretion (pancreas)
increased glucagon secretion (pancreas)
decreased incretin effect (gut peptide)
increased hepatic glucose production (liver)
neurotransmitter dysfunction
increased lipolysis
increased glucose reabsorption (kidneys)
decreased glucose uptake (muscles)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why is the prevalence of T2DM increasing more than the incidence

A

as people are living longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what ethnic group has a higher risk of diabetes

A

eastern Asian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

insulin resistance is more assocaited with micro/macro vascular disease

A

macro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hyperglycaemia is more associated with micro/macro vascular disease

A

micro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is CVD risk most effectively treated

A

statins/ anti-hypertensives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when is one blood test diagnostic for diabetes

A

when its over diagnostic limit and patient is symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the treatment areas for T2DM

A

lifestyle changes
glycaemic management- metformin (most), insulin (last line)
blood pressure management
lipid management- statin
antiplatelet therapy- aspirin, clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the treatment for acute T2DM

A

basal bolus insulin

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the first line treatment give to most people for glycaemic control

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the mechanism of metformin

A

decreases hepatic gluconeogenesis

increased peripheral glucose uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what outcomes does metformin usually have

A

decreases HbA1c
weight neutral
no hypoglycaemia control when used as monotherapy
decreased Cancer and CHD risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are some adverse effects of metformin

A

GI, lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what can metformin be combined with as a second step

A
SGLT2
glitazone
gliptin 
GLP-1R
SU
basal insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the mechanism of sulphonylurea

A

blocks beta cell KATP channels , increased 1st and 2nd phase insulin secretion

17
Q

what are the outcomes seen when using sulphonylurea

A

decrease in HbA1c
weight gain
hypoglycaemia

18
Q

what are adverse effects of sulphonylurea

A

abnormal LFTs

increased CHD

19
Q

name a sulphonylurea

A

gliclazide

20
Q

what is the maximum effective dose of gliclazide

A

80-120mg

21
Q

what happens as the dose of sulphonylureas is increased

A

efficacy is reduced

22
Q

what are gliptins

A

e.g. GLP-1 receptor agonist and DPP4 inhibitors

23
Q

how do DPP 4 inhibitors work

A

blocks action of DDP- an enzyme that destroys the hormone incretin

24
Q

how does GLP-1 receptor work

A

is an incretin- increases secretion insulin and somatostatin, reduces secretion of glucagon

25
Q

what are the outcomes of GLP-1 receptor agonists

A

lower HbA1c

increase in weight

26
Q

can GLP-1 help with hypoglycaemia

A

when used in combination with metformin and/or a sulphonylurea

27
Q

what is the outcome of DPP4 inhibitors

A

decrease HbA1c

weight neutral or decreased

28
Q

what do SGLT-2 inhibitors do

A

reduce the amount of glucose being absorbed in the kidneys, passed out in the urine instead of being reabsorbed into the blood

29
Q

how does glitazone work

A

lower insulin resistance, increasing peripheral glucose uptake via PPAYgamma activator

30
Q

what are the outcomes of glitazone

A

decrease HbA1c

increase weight

31
Q

what are the adverse affectes of glitazone

A

fracture risk increase
hepatoxicity
fluid retention

32
Q

what should you consider if drugs not working

A

adding on another instead of titrating up the dosage

33
Q

what is the max dosage or metformin

A

1000mg bid

34
Q

what is given if there is a history of cardiovascular disease

A

metformin + SGLT2